Keyphrases
Amyotrophic Lateral Sclerosis
20%
Beneficial Effects
13%
Bioactive Lipids
8%
CD200
8%
CD300a
8%
Central Nervous System Injury
8%
Cyclooxygenase-2
9%
Experimental Autoimmune Encephalomyelitis
13%
Functional Deficits
7%
Functional Improvement
8%
Functional Recovery
22%
Gene Therapy
8%
IL-37
16%
Immunoreceptor
8%
Inducible Nitric Oxide Synthase
7%
Inflammation
25%
Inflammation Resolution
8%
Inflammatory Response
9%
Injured Spinal Cord
7%
Interleukin-1β
8%
Interleukin-4 (IL-4)
9%
LPA1
8%
LPA2
8%
Lysophosphatidic Acid
15%
Lysophosphatidic Acid Receptor
21%
Macrophages
22%
Maresins
8%
Microglia
24%
Motor Evoked Potential
10%
Neuregulin-1 (NRG1)
8%
Neuroinflammation
10%
Olfactory Ensheathing Cells
25%
OLT1177
8%
Overexpressing
8%
Partial Recovery
8%
Phospholipase A2 (PLA2)
16%
Pro-resolving Lipid Mediators
7%
Pro-resolving Mediators
8%
Rat Spinal Cord
7%
Receptor Subtypes
12%
Secondary Damage
17%
Skeletal muscle
7%
SOD1G93A Mice
8%
Spinal Cord
44%
Spinal Cord Compression
10%
Spinal Cord Contusion Injury
11%
Spinal Cord Injury
100%
Tissue Damage
14%
Transplantation
13%
αB-crystallin
8%
Neuroscience
Amyotrophic Lateral Sclerosis
21%
Anti-Inflammatory
8%
Astrocyte
5%
Axon
5%
Blood Brain Barrier
8%
Calcium Independent Phospholipase A2
5%
Central Nervous System
11%
Crystallin
8%
Cytosolic Phospholipase A2
6%
Experimental Autoimmune Encephalomyelitis
9%
Gliosis
5%
Gray Matter
6%
In Vitro
5%
Interleukin 37
8%
Lysophosphatidic Acid
10%
Lysophosphatidic Acid Receptor
16%
Macrophage
31%
Maresin
8%
Microglia
32%
Motor Evoked Potential
23%
Myelin
14%
Nervous System
6%
Nervous System Regeneration
5%
Neu Differentiation Factor
8%
Neuroprotection
5%
Neutrophil Granulocyte
6%
Olfactory Bulb
8%
Parenchyma
9%
Peripheral Nerve
9%
Peripheral Nerve Injury
5%
Phospholipase A
6%
Phospholipase A2
12%
Proteoglycan
8%
Receptor
12%
Reinnervation
5%
Schwann Cell
5%
Sciatic Nerve
9%
Skeletal Muscle
7%
Somatosensory Evoked Potential
10%
Spinal Cord Injury
53%
Spinal Cord Injury
46%
Wallerian Degeneration
6%
